Inflammation-reducing molecule provides a new target for treating atherosclerosis

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup